Search Results 91-100 of 16300 for monoclonal antibody
This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This drug helps reduce relapses of MS by ...
Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...
Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...
It is a monoclonal antibody that changes the immune system to help control the growth of cancer cells in the skin. Ipilimumab injection is also used to help ...
The HER2 protein is produced by some breast tumors. Pertuzumab is a monoclonal antibody that interferes with the growth of this protein, which is eventually ...
The newly approved treatments are three monoclonal antibodies: ... Rituximab, a monoclonal antibody often used to treat NMOSD , costs about $18,000 a year.
Infliximab-axxq is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Fraker JL, Clune CG, Sahni SK ...
... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.